J

Women and Cardiometabolic Disease: Can Pregnancy Complications Reveal Increased Risk for Diabetes or CV Disease?

By Jacinda Nicklas 4 Videos
April 28, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

01:52
Novo Nordisk – GLP-1 RA Therapy

T2D Treatment After Oral Agents: What Is the Next Step?

Feat. C. Wierum, L. Coco

Featured Video

01:13
Novo Nordisk – GLP-1 RA Therapy

ADA Guidelines for T2D: What Is the Preferred Next Step After Oral Agents?

Feat. C. Wierum, L. Coco

Related Content

AUTOPLAY
15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Can it be a…

24:43
UChicago Medicine

Precision Medicine & Atypical Diabetes

Feat. L. Philipson
27:47
Icahn School of Medicine

Harnessing Social Media for Home Dialysis

Feat. S. Farouk
10:02
Emory Diabetes Education Training Academy

Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combinatio…

Feat. G. Umpierrez
28:29
Icahn School of Medicine

Peritoneal Dialysis (PD) - Associated Peritonitis: Suggestions for Managem…

Feat. J. Perl
14:52
Richard Pratley

Highlights From the 81st ADA Scientific Sessions: The AMPLITUDE Study

23:56
Icahn School of Medicine

Clinical Implications of Changes in Peritoneal Membrane Characteristics Ov…

Feat. R. Krediet
09:24
Cardiometabolic Health Congress (CMHC)

SGLT-2 Inhibitors & GLP-1 RAs in CV Risk: What Have We Learned From CV…

Feat. R. Eckel
26:17
John Tayek

2020 Updates on Insulin Therapy: What Are the Current ADA Standards of Car…

11:31
Domenica Rubino

Weight Loss Maintenance for Adults With Once-Weekly Semaglutide: What Was …

05:50
Michael J. Haller

Severe Hypoglycemia: What Is the Newest Glucagon Treatment? What Is the Co…

06:33
Jacinda Nicklas

Overcoming Postpartum Barriers To Diabetes Prevention: What Are the Observ…

08:21
Cardiometabolic Health Congress (CMHC)

What Are the Current Trends of CKD in T2D?

Feat. G. Bakris
11:29
Robin Conway

Hypoglycemia Classification: What Are Important Factors to Consider When D…

06:25
Cleveland Clinic Endocrinology & Metabolism Institute

Hyperglycemia in Non-ICU Settings: What Is the Epidemiology?

Feat. G. Umpierrez
05:50
Mayo Clinic Proceedings

Perioperative Evaluation & Endocrine Disorders: What Are the Medicatio…

Feat. C. Himes
21:59
Melinda Maryniuk

2021 ADA Highlights: Diabetes Diets Since the Discovery of Insulin: 1921-1…

12:37
David Wheeler

2021 ADA Highlights: Landmark DAPA-CKD Trial in Kidney Disease: Extending …

28:31
Practical Ways to Achieve Targets in Diabetes Care

Hybrid Closed Loop (HCL) Systems

Feat. E. Cengiz
33:40
Ralph DeFronzo

2021 ADA Highlights: Selecting Glucose Lowering Combinations for Type 2 Di…